Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

APP processing and the APP-KPI domain involvement in the amyloid cascade.

M Menéndez-González1, P Pérez-Pinera, M Martínez-Rivera

  • 1Neurology Department, Hospital Universitario Central de Asturias, Oviedo, Spain. manuelmenendez@gmail.com

Neuro-Degenerative Diseases
|August 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of manipulative skills on quality of life and activities of daily living in multiple sclerosis.

Revista de neurologia·2024
Same author

A variant in GRN of Spanish origin presenting with heterogeneous phenotypes.

Neurologia·2022
Same author

Myoclonic epilepsy in Down syndrome and Alzheimer disease.

Neurologia (Barcelona, Spain)·2015
Same author

Patterning small-molecule biocapture surfaces: microcontact insertion printing vs. photolithography.

Chemical communications (Cambridge, England)·2011
Same author

Expression and cell localization of brain-derived neurotrophic factor and TrkB during zebrafish retinal development.

Journal of anatomy·2010
Same author

Differential localization of Acid-sensing ion channels 1 and 2 in human cutaneus pacinian corpuscles.

Cellular and molecular neurobiology·2010

The Kunitz protease inhibitor (KPI) domain in amyloid precursor protein (APP) is elevated in Alzheimer's disease (AD) brains, contributing to amyloid beta deposition and disease pathogenesis.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Alternative splicing of amyloid precursor protein (APP) mRNA generates isoforms containing a Kunitz protease inhibitor (KPI) domain.
  • KPI is a significant serine protease inhibitor.
  • Elevated levels of KPI(+)APP protein and mRNA are observed in Alzheimer's disease (AD) brains, correlating with increased amyloid beta deposition.

Purpose of the Study:

  • To review the role of KPI(+)APP in Alzheimer's disease pathogenesis.
  • To explore APP processing and the molecular activity of KPI.
  • To examine the physiological and pathological roles of KPI.

Main Methods:

  • Literature review focusing on APP processing.
  • Analysis of KPI's molecular activity and its roles.

Related Experiment Videos

  • Investigation of KPI's involvement in the amyloid cascade via specific pathways.

    • Main Results:

    • Accumulating evidence highlights multiple points in the amyloid cascade where KPI(+)APP is implicated.
    • The KPI domain holds a significant position in AD pathogenesis.
    • KPI(+)APP influences the amyloid cascade through interactions with nerve growth factor, LRP, TACE, and Notch1.

    Conclusions:

    • The KPI domain is a key player in the pathogenesis of Alzheimer's disease.
    • Understanding KPI's role in APP processing and the amyloid cascade is crucial for AD research.
    • Further investigation into KPI's interactions may reveal novel therapeutic targets for AD.